cp wire

CP Wire Articles

FDA Grants Priority Review and accepts BLA for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer
  • PDUFA target date is 1/18/19
  • Sacituzumab govitecan is an antibody drug conjugate (ADC)
  • If appproved it would be the first ADC approved for mTNBC
  • Company has another... read more
Wed, 07/18/18 - 09:27 am
[sponsored] Speaker Book - The App That Exposes Conflicts of Interest in the Pharmaceutical Industry

SPEAKER BOOK APP is the platform where patients advocates, doctors, and biotech investors can look at conflicts of interest in Pharma to understand what is going on under the surface of... read more

Tue, 07/17/18 - 03:25 pm
FDA Taking Steps to Empower Consumers' Use of Nonprescription Drugs


FDA commissioner, Scott Gottleib, released a statement on 7/17/18 discussing new draft guidance related... read more

Tue, 07/17/18 - 10:18 am
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European Union
  • Company received $49 million dollar funding round in November of 2017
  • INZ-701 received Orphan Drug Designation in both US and Europe

Inozyme Pharma (Inozyme) announced... read more

Tue, 07/17/18 - 09:41 am
Microbiome report week ending 7-14-18

Tue, 07/17/18 - 09:35 am

Pages